Organon & Co. Statistics

Total Valuation

Organon & Co. has a market cap or net worth of EUR 2.52 billion. The enterprise value is 9.88 billion.

Market Cap	2.52B
Enterprise Value	9.88B

Important Dates

The next estimated earnings date is Friday, May 2, 2025.

Earnings Date	May 2, 2025
Ex-Dividend Date	Feb 21, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+1.13%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	256.82M

Valuation Ratios

The trailing PE ratio is 3.02.

PE Ratio	3.02
Forward PE	n/a
PS Ratio	0.41
PB Ratio	5.53
P/TBV Ratio	n/a
P/FCF Ratio	3.42
P/OCF Ratio	2.78
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.14, with an EV/FCF ratio of 13.38.

EV / Earnings	11.83
EV / Sales	1.75
EV / EBITDA	6.14
EV / EBIT	7.55
EV / FCF	13.38

Financial Position

The company has a current ratio of 1.60, with a Debt / Equity ratio of 19.14.

Current Ratio	1.60
Quick Ratio	0.80
Debt / Equity	19.14
Debt / EBITDA	4.94
Debt / FCF	11.83
Interest Coverage	2.86

Financial Efficiency

Return on equity (ROE) is 429.85% and return on invested capital (ROIC) is 10.13%.

Return on Equity (ROE)	429.85%
Return on Assets (ROA)	7.39%
Return on Invested Capital (ROIC)	10.13%
Return on Capital Employed (ROCE)	14.33%
Revenue Per Employee	618,466
Profits Per Employee	83,454
Employee Count	10,000
Asset Turnover	0.51
Inventory Turnover	2.04

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.87% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-11.87%
50-Day Moving Average	14.78
200-Day Moving Average	16.52
Relative Strength Index (RSI)	12.54
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.20

Income Statement

In the last 12 months, Organon & Co. had revenue of EUR 6.18 billion and earned 834.54 million in profits. Earnings per share was 3.22.

Revenue	6.18B
Gross Profit	3.59B
Operating Income	1.44B
Pretax Income	779.48M
Net Income	834.54M
EBITDA	1.70B
EBIT	1.44B
Earnings Per Share (EPS)	3.22

Full Income Statement

Balance Sheet

The company has 651.98 million in cash and 8.73 billion in debt, giving a net cash position of -8.08 billion.

Cash & Cash Equivalents	651.98M
Total Debt	8.73B
Net Cash	-8.08B
Net Cash Per Share	n/a
Equity (Book Value)	455.90M
Book Value Per Share	1.77
Working Capital	1.57B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 906.98 million and capital expenditures -169.03 million, giving a free cash flow of 737.95 million.

Operating Cash Flow	906.98M
Capital Expenditures	-169.03M
Free Cash Flow	737.95M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 58.02%, with operating and profit margins of 23.24% and 13.49%.

Gross Margin	58.02%
Operating Margin	23.24%
Pretax Margin	12.60%
Profit Margin	13.49%
EBITDA Margin	27.57%
EBIT Margin	23.24%
FCF Margin	11.93%

Dividends & Yields

This stock pays an annual dividend of 1.04, which amounts to a dividend yield of 7.25%.

Dividend Per Share	1.04
Dividend Yield	7.25%
Dividend Growth (YoY)	0.97%
Years of Dividend Growth	n/a
Payout Ratio	34.38%
Buyback Yield	-1.13%
Shareholder Yield	6.12%
Earnings Yield	33.08%
FCF Yield	29.25%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Organon & Co. has an Altman Z-Score of 1.35. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.35
Piotroski F-Score	n/a